PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 48 filers reported holding PROQR THRAPEUTICS N V in Q4 2020. The put-call ratio across all filers is 13.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $286,000 | -80.9% | 315,080 | +68.8% | 0.00% | -100.0% |
Q4 2021 | $1,495,000 | +18.0% | 186,663 | +23.3% | 0.00% | 0.0% |
Q3 2021 | $1,267,000 | +52.7% | 151,402 | +23.0% | 0.00% | +50.0% |
Q2 2021 | $830,000 | +330.1% | 123,083 | +205.1% | 0.00% | +100.0% |
Q3 2020 | $193,000 | +14.9% | 40,342 | +46.1% | 0.00% | 0.0% |
Q2 2020 | $168,000 | +93.1% | 27,612 | +74.8% | 0.00% | 0.0% |
Q1 2020 | $87,000 | -37.9% | 15,798 | +12.1% | 0.00% | 0.0% |
Q4 2019 | $140,000 | – | 14,087 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |